Berlin (AFP) Aug 5, 2020
Clinical trials on humans have begun in China for a potential coronavirus vaccine developed by German pharmaceutical group BioNTech with Chinese company Fosun Pharma, the companies said Wednesday. Seventy-two participants have already received their first dose following approval for the phase 1 trial from Chinese regulatory authorities, BioNTech and Fosun Pharma said in a statement. The
German-Chinese coronavirus vaccine trial begins in China
Terra Daily
0 shares
1 views
You might like
Related news coverage
Peru seeks 6,000 volunteers for China vaccine trial
Terra Daily
Lima (AFP) Aug 26, 2020
Peru on Wednesday began registering volunteers for clinical trials of a Chinese vaccine against..
-
Canada strikes more deals for COVID-19 vaccine, but may have to wait in line behind other nations
National Post
-
S&P 500 and Nasdaq hit highs as Apple snaps 5-day winning streak
Proactive Investors
-
Wall Street still mixed as traders digest data
Proactive Investors
-
Wall Street shares paint mixed picture after recent records from S&P 500 and Nasdaq
Proactive Investors
Advertisement
More coverage
Global stocks tick higher after 'constructive' US-China trade talks conclude and investors pin hopes on early development of a vaccine
Business Insider
· *Global stocks climbed on Tuesday after the US and China held "constructive" talks about their Phase One trade deal.*
·..
-
FTSE 100 closes firmly down as Wall Street mixed
Proactive Investors
-
Report: Chinese mining company used COVID-19 vaccine in PNG
SeattlePI.com